Mairs & Power Balanced Fund Cautious on Abbott Laboratories Amid Nutrition Business Concerns
The Mairs & Power Balanced Fund reported a -1.77% return in Q1 2026, outperforming its benchmark index decline of -2.68%. The fund cited strong stock selection and exposure to Utilities and Industrials as key factors amid market volatility from the Iran conflict and rising energy prices. However, it noted that Abbott Laboratories (ABT) negatively impacted performance due to slowing growth in its nutrition business.
Tickers: $ABT